BMO's initiation is a neutral-to-slightly-positive data point in an already bullish consensus. The flat PT and heavy insider selling suggest limited near-term upside. Traders should wait for a pullback or a stronger catalyst (e.g., earnings on Aug 27) before adding long exposure.
Price Chart
Executive Summary
BMO Capital initiated coverage on Marvell Technology (MRVL) at Outperform with a $250 price target, essentially in line with the current price of $251.01. The call adds to an already bullish consensus: 42 of 49 analysts rate MRVL Buy or Strong Buy, 7 rate Hold, and none rate Sell. The mean price target is $259.91, implying ~3.5% upside, while the median is $247.50. BMO's 53% accuracy on 1,841 calls is slightly above average, and its average return of +2.3% per call is solid. The initiation is consensus-aligned and not contrarian, so the impact is moderate. EPS revisions have been positive — 23 upward revisions for the current quarter in the last 7 days, with no downward revisions. Insider selling is notable, with five C-suite sales totaling ~$9.8M over the past two months, but these are routine liquidity events. Institutional activity is mixed: two large funds trimmed significantly, while three added. The bottom line: BMO's initiation adds a fresh bullish voice to an already crowded bull case, but the flat PT offers no immediate catalyst for a breakout.
Impact Score
Consensus & Targets
Of 49 analysts covering MRVL, 13 rate Strong Buy, 29 rate Buy, and 7 rate Hold. Zero Sell or Strong Sell ratings. The consensus is overwhelmingly bullish, with 85.7% Buy-equivalent ratings. This initiation adds to that direction.
Mean PT is $259.91, median $247.50, high $400 (Keybanc), low $126. Current price $251.01 implies 3.5% upside to the mean. BMO's $250 PT sits slightly below the mean and just above the median, in the middle of the pack. The wide range ($126–$400) reflects significant disagreement on valuation.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-21 | BMO Capital | initiate | Outperform | $250.00 |
| 2026-08-20 | UBS | maintain | Buy | $310.00 |
| 2026-08-20 | RBC Capital | reiterate | Outperform | $360.00 |
| 2026-08-18 | TD Cowen | maintain | Hold | $225.00 |
| 2026-08-17 | UBS | maintain | Buy | $300.00 |
| 2026-07-14 | Keybanc | maintain | Overweight | $400.00 |
| 2026-07-07 | RBC Capital | reiterate | Outperform | $360.00 |
| 2026-06-29 | UBS | maintain | Buy | $340.00 |
| 2026-06-29 | Cantor Fitzgerald | maintain | Neutral | $300.00 |
| 2026-06-24 | Stifel | maintain | Buy | $350.00 |
In the last 30 days, there has been 1 upgrade (this initiation) and 0 downgrades. EPS revisions are positive: 23 upward revisions for the current quarter (0q) in the last 7 days, 0 downward. For the next quarter (+1q), 1 upward revision and 0 downward. Estimates are being revised higher across all timeframes.
Firm Track Record — BMO Capital
BMO Capital accuracy: 53% on 1841 calls | avg return: 2.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Deutsche Bank | 67% | 2/3 | -4.9% | top tier |
| Evercore ISI Group | 57% | 4/7 | 2.2% | above average |
| Cantor Fitzgerald | 57% | 4/7 | 10.2% | above average |
| Needham | 56% | 5/9 | 1.3% | above average |
| Morgan Stanley | 56% | 5/9 | 0.6% | above average |
| Loop Capital | 50% | 2/4 | -1.9% | below average |
| Oppenheimer | 50% | 3/6 | 0.8% | below average |
| Wells Fargo | 50% | 3/6 | -5.5% | below average |
| Raymond James | 50% | 1/2 | -0.4% | below average |
| Benchmark | 50% | 4/8 | 3.1% | below average |
BMO Capital has a 53% accuracy rate on 1,841 calls, with an average return of +2.3% per call. This is slightly above the average of firms covering MRVL. Among peers, Deutsche Bank leads at 67% accuracy (3 calls), while B of A Securities is worst at 33% (6 calls). BMO's track record is solid but not elite.
Earnings Estimates
Next earnings: Aug 27, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| +1q | $1.07 | $1.01 — $1.11 | $3.0B | ↑1 ↓0 |
| +1y | $6.25 | $5.34 — $7.89 | $16.8B | ↑2 ↓0 |
| 0q | $0.93 | $0.88 — $0.94 | $2.7B | ↑23 ↓0 |
| 0y | $4.05 | $3.81 — $4.20 | $11.5B | ↑1 ↓0 |
Cross-Platform Signals
Insider selling is heavy: five C-suite sales totaling ~$9.8M over the past two months, including CFO Matthew Murphy ($1.77M on Aug 17) and EVP Chris Koopmans ($1.8M on Aug 3). These are routine sales (likely 10b5-1), not panic selling. Congressional activity is bullish: Rep. Ro Khanna (D-CA) bought $15k–$50k on Jul 7 and $1k–$15k on Jun 5. Institutional activity is mixed: Ameriprise trimmed 56.4% and Wellington trimmed 68.5%, while Amundi added 80.6% and RBC added 35.2%. Short interest is 57.7% of float, elevated but not extreme. The insider selling diverges from the bullish analyst signal, but per academic literature, insider sales are weak predictors and likely liquidity-driven.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 9d ago | ANALYST-UPGRADE | $260.90 $260.54 | ▼ −0.14% | ▼ −0.27% | $268.08 (+2.75%) |
Sep 10, 2026 21d ago | ANALYST-UPGRADE | $226.96 $240.76 | ▲ +6.08% | ▲ +6.58% | $268.08 (+18.12%) |
Sep 1, 2026 4w ago | 144 | $206.45 $226.96 | ▲ +9.94% | ▲ +10.89% | $268.08 (+29.85%) |
Aug 21, 2026 6w ago | ANALYST-UPGRADE | $237.04 $216.62 | ▼ −8.61% | ▼ −9.09% | $268.08 (+13.09%) |
Aug 19, 2026 6w ago | 8-K | $237.27 $245.11 | ▲ +3.30% | ▲ +3.69% | $268.08 (+12.99%) |
Aug 17, 2026 6w ago | 144 | $216.00 $240.38 | ▲ +11.29% | ▲ +11.49% | $268.08 (+24.11%) |
Jul 17, 2026 11w ago | Insider Cluster | $188.68 $209.32 | ▲ +10.94% | ▲ +11.63% | $268.08 (+42.08%) |
Jun 25, 2026 14w ago | 8-K | $266.77 $245.29 | ▼ −8.05% | ▼ −10.22% | $268.08 (+0.49%) |
Jun 23, 2026 14w ago | 144 | $276.70 $272.05 | ▼ −1.68% | ▼ −3.39% | $268.08 (−3.12%) |
Jun 17, 2026 15w ago | Insider Cluster | $310.58 $281.26 | ▼ −9.44% | ▼ −7.77% | $268.08 (−13.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access